[1]
“Bosentan for patients with steroid-resistant pulmonary sarcoidosis: a randomised controlled trial”, Swiss Med Wkly, vol. 148, no. 4344, p. w14677, Oct. 2018, doi: 10.4414/smw.2018.14677.